Biegel & Waller’s Immunomedics Inc IMMU Stock Holding History

Biegel & Waller’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$172K	Hold	13,000	–	–	0.1%	69
2019 Q2	$180K	Hold	13,000	–	–	0.09%	75
2019 Q1	$250K	Hold	13,000	–	–	0.13%	65
2018 Q4	$186K	Hold	13,000	–	–	0.11%	69
2018 Q3	$271K	Hold	13,000	–	–	0.16%	59
2018 Q2	$308K	Hold	13,000	–	–	0.19%	49
2018 Q1	$190K	Hold	13,000	–	–	0.12%	54
2017 Q4	$210K	Hold	13,000	–	–	0.12%	53
2017 Q3	$182K	Hold	13,000	–	–	0.11%	51
2017 Q2	$115K	Hold	13,000	–	–	0.07%	55
2017 Q1	$84K	Hold	13,000	–	–	0.06%	48
2016 Q4	$56K	Buy	+13,000	New	+$38.5K	0.04%	53

Other funds holding IMMU

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Biegel & Waller's IMMU Position: Q3 2019 in Review

Biegel & Waller held its Immunomedics Inc (IMMU) position steady in Q3 2019 at 13,000 shares worth $172K. The position accounts for 0.1% of the portfolio, ranked #69.

Biegel & Waller first reported a position in IMMU in Q4 2016 and has held it in 12 quarters since. The position peaked at $308K in Q2 2018. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

Biegel & Waller held 13,000 shares of Immunomedics Inc worth $172K as of Q3 2019.
Biegel & Waller left its Immunomedics Inc share count unchanged in Q3 2019.
Immunomedics Inc made up 0.1% of Biegel & Waller's portfolio in Q3 2019, its #69 holding.
Biegel & Waller first reported a position in Immunomedics Inc in Q4 2016 and has held it in 12 quarters since.
Biegel & Waller's Immunomedics Inc position peaked at $308K in Q2 2018.
208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Biegel & Waller's 13F filing for Q3 2019, filed 15 Oct 2019.